HTG Molecular Diagnostics, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 9 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-08-16: Reporting owner McMeans Shaun D; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-08-16: Reporting owner Lubniewski John L; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-08-16: Reporting owner JOHNSON TIM B; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-08-15: Reporting owner LAFRANCE JAMES T; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-08-16 | McMeans Shaun D Officer (SVP, Finance & Admin. & CFO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $3.40 exercise price | 2018-08-17 | |
| 2018-08-16 | Lubniewski John L Officer (President & COO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $3.40 exercise price | 2018-08-17 | |
| 2018-08-16 | JOHNSON TIM B Director, Officer (CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $3.40 exercise price | 2018-08-17 | |
| 2018-08-15 | LAFRANCE JAMES T Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $3.31 exercise price | 2018-08-17 | |
| 2018-08-15 | McCracken Lee R. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $3.31 exercise price | 2018-08-17 | |
| 2018-08-15 | HARDISON DON M Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $3.31 exercise price | 2018-08-17 | |
| 2018-08-15 | George Harry A. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $3.31 exercise price | 2018-08-17 | |
| 2018-08-15 | HANHAM ANN Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $3.31 exercise price | 2018-08-17 | |
| 2018-08-15 | GRIFFIN MICHELLE RENEE Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $3.31 exercise price | 2018-08-17 |